Home › Amyloidosis › Indiana
Amyloidosis clinical trials in Indiana
3 studies for Amyloidosis are looking for participants at sites in Indiana.
Cities in Indiana
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Indianapolis
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Indianapolis
- Clinical Trial Site, Indianapolis
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Indiana University Health, Indianapolis
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.